Aurobindo Pharma shares rise nearly 7 percent after Q2 results

Published On 2020-11-14 04:00 GMT   |   Update On 2020-11-14 04:01 GMT

New Delhi: Shares of Aurobindo Pharma on Thursday gained nearly 7 percent in early trade after the company reported a 26 percent increase in consolidated net profit in the second quarter ended September.After opening in the green, the stock further jumped 6.47 percent to Rs 863.60 on the BSE.On the NSE, shares of the company rose by 6.56 percent to Rs 864.Aurobindo Pharma on Wednesday reported...

Login or Register to read the full article

New Delhi: Shares of Aurobindo Pharma on Thursday gained nearly 7 percent in early trade after the company reported a 26 percent increase in consolidated net profit in the second quarter ended September.

After opening in the green, the stock further jumped 6.47 percent to Rs 863.60 on the BSE.

On the NSE, shares of the company rose by 6.56 percent to Rs 864.

Aurobindo Pharma on Wednesday reported a 26 percent increase in consolidated net profit at Rs 805.65 crore in the second quarter ended September.

The company had posted a consolidated net profit of Rs 639.53 crore in the same quarter last fiscal, Aurobindo Pharma said in a regulatory filing.

Consolidated total revenue from operations during the period under review stood at Rs 6,483.44 crore as against Rs 5,600.47 crore in the corresponding quarter last fiscal, it added.

Aurobindo Pharma Managing Director N Govindarajan said: "We continue to perform well across all our key geographies and segments to report a consistent set of earnings."


Tags:    
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News